Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis

J Clin Invest. 2024 Mar 1;134(5):e180162. doi: 10.1172/JCI180162.
No abstract available

MeSH terms

  • B7-H1 Antigen / genetics
  • B7-H1 Antigen / metabolism
  • Humans
  • Leishmaniasis, Cutaneous* / drug therapy
  • Skin Neoplasms* / metabolism

Substances

  • B7-H1 Antigen